Profile
Matthew Bartholomae is currently working as the Secretary & General Counsel at Cartesian Therapeutics, Inc. He previously worked as Counsel at Minerva Neurosciences, Inc. from 2016 to 2018 and as Secretary & General Counsel at Selecta Biosciences, Inc. from 2019 to 2023.
Mr. Bartholomae completed his undergraduate degree at Boston College and his graduate degree at the University of New Hampshire School of Law.
Matthew Bartholomae active positions
| Companies | Position | Start |
|---|
Former positions of Matthew Bartholomae
| Companies | Position | End |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | General Counsel | 2023-10-31 |
| MINERVA NEUROSCIENCES, INC. | Corporate Officer/Principal | 2017-12-31 |
Training of Matthew Bartholomae
| Boston College | Undergraduate Degree |
| University of New Hampshire School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MINERVA NEUROSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
- Stock Market
- Insiders
- Matthew Bartholomae
